February 16, 2026 · Form 4 insider transaction
Torley Helen sold 27,605 shares of Halozyme Therapeutics, Inc. at $79.44 per share, a transaction worth $2.19M. The trade was recorded as shares withheld for taxes and disclosed on an SEC Form 4, filed 1 day after the transaction.
The reported disposition of 27,605 shares represents the shares that were withheld by the issuer as payment for tax withholding obligations.